MedPath

Opioid Free Anaesthesia for Postoperative Pain control in Bariatric Surgery

Phase 2
Not yet recruiting
Conditions
Obesity, unspecified,
Registration Number
CTRI/2020/07/026378
Lead Sponsor
GEM Hospital and Research centre
Brief Summary

Anaesthetic challenge in bariatric surgery includes postoperative pain relief as its vital component. Owing to have better pain control, early mobilisation and faster recovery it is better to reduce the use of respiratory depressants. Furthermore, perioperative cognitive dysfunction and opioid induced hyperalgesia remains a concern with any opioid based technique. Therefore our study aims at comparing opioid free anaesthesia for postoperative pain relief and attenuation of intubation stress response with opioid anaesthesia group in patients undergoing laparoscopic sleeve gastrectomy.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Patients aged between 25 to 60 years.

Exclusion Criteria

Patients with severe bradycardia,uncontrolled hypertension,heart blocks.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare pain score between two groupsDifferent time points,Immediately after extubation followed by half an hour hourly for two hours,then fourth hourly for till 24 hours
Secondary Outcome Measures
NameTimeMethod
Intubation stress response,discharge readiness,post operative opioid consumption,sedation score,post operative nausea and vomitingDifferent time points,immediately after intubation followed by every minute for ten minutes,postoperatively every half an hour for two hours followed by every fourth hourly till 24 hours

Trial Locations

Locations (1)

GEM Hospital and Research centre

🇮🇳

Coimbatore, TAMIL NADU, India

GEM Hospital and Research centre
🇮🇳Coimbatore, TAMIL NADU, India
Dr Prabhakaran
Principal investigator
9894282831
prabhakar.s.doc@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.